Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure (Q43832647)

27 November 2017

title

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure (English)

1 reference

27 November 2017

1 reference

1 reference

chronic heart failure

1 reference

W H Wilson Tang

1

1 reference

27 November 2017

Randall H Vagelos

2

1 reference

27 November 2017

Yin Gail Yee

3

1 reference

27 November 2017

Claude R Benedict

4

1 reference

27 November 2017

Kathy Willson

5

1 reference

27 November 2017

Charles L Liss

6

1 reference

27 November 2017

Michael B Fowler

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Journal of the American College of Cardiology

27 November 2017

published in

1 reference

27 November 2017

volume

39

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

70-78

1 reference

Determinants of angiotensin II generation during converting enzyme inhibition

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

WITHIN-PATIENT VARIABILITY OF HORMONE AND CYTOKINE CONCENTRATIONS IN HEART FAILURE

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Long-term effects of a once-a-day versus twice-a-day regimen of enalapril for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Once daily dosing of enalapril in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Pharmacokinetic profiles of single and repeat doses of lisinopril and enalapril in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Effects of enalapril on different aspects of the clinical state in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901714-4

7 January 2021

10.1016/S0735-1097(01)01714-4

Identifiers

DOI

1 reference

27 November 2017

1 reference